Testing effectiveness (Phase 2)Ended earlyNCT05448677
What this trial is testing
Ezurpimtrostat Autophagy Inhibitor in Association With Atezolizumab-Bevacizumab in First Line Treatment of Unresectable Hepatocellular Carcinoma
Who this might be right for
Hepatocellular Carcinoma
University Hospital, Grenoble 3